La vacuna contra el virus del papiloma humano: estado de la cuestión, principio de proporcionalidad y consentimiento informado

dc.contributor.authorPinto-Bustamante, Boris Julián
dc.contributor.orcidPinto-Bustamante, Boris Julián [0000-0002-2463-4214]
dc.contributor.orcidPinto-Bustamante, Boris Julián [0000-0002-2463-4214]
dc.date.accessioned2020-07-16T14:36:44Z
dc.date.available2020-07-16T14:36:44Z
dc.date.issued2016
dc.description.abstractenglishWithin the current discussions on immunization practices, Human Papillomavirus (HPV) made various challenges from bioethics: firstly, there are controversies regarding the efficacy and safety profile of marketed vaccines, and with respect to their cost-effectiveness. Around the discussion is evident in empirical studies that the informed consent process does not provide the necessary elements for the patients and their legal representatives can participate meaningfully in the process of making decisions about vaccination. This article presents an overview of the status of the issue, with an analysis from bioethics from the principle of proportionality and the deliberative syncretic method and suggests some input to optimize the process of informed consent for the HPV vaccine.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://dx.doi.org/10.4067/S1726-569X2016000200012
dc.identifier.instnameinstname:Universidad El Bosquespa
dc.identifier.issn1726-569X
dc.identifier.reponamereponame:Repositorio Institucional Universidad El Bosquespa
dc.identifier.repourlhttps://repositorio.unbosque.edu.co
dc.identifier.urihttps://hdl.handle.net/20.500.12495/3521
dc.language.isospa
dc.publisherOPS/OMS, Unidad de Bioeticaspa
dc.publisher.journalActa bioethicaspa
dc.relation.ispartofseriesActa bioethica, 1726-569X, Vol. 22, Nro. 2, 2016, p. 251-261spa
dc.relation.urihttps://scielo.conicyt.cl/scielo.php?script=sci_abstract&pid=S1726-569X2016000200012&lng=es&nrm=iso&tlng=en
dc.rightsAttribution 4.0 International*
dc.rights.accessrightshttps://purl.org/coar/access_right/c_abf2
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.accessrightsAcceso abierto
dc.rights.creativecommons2016-11
dc.rights.localAcceso abiertospa
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectVacunaciónspa
dc.subjectProgramas de inmunizaciónspa
dc.subjectVacunas contra papillomavirusspa
dc.subject.decsBioéticaspa
dc.subject.decsConsentimiento Informadospa
dc.subject.decsAnálisis costo-beneficiospa
dc.subject.keywordsVaccinationspa
dc.subject.keywordsImmunization programspa
dc.subject.keywordsPapillomavirus vaccinesspa
dc.titleLa vacuna contra el virus del papiloma humano: estado de la cuestión, principio de proporcionalidad y consentimiento informadospa
dc.title.translatedThe vaccine against human papilloma virus: state of the question, proportionality principle and informed consentspa
dc.type.coarhttps://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.type.hasversioninfo:eu-repo/semantics/publishedVersion
dc.type.localArtículo de revista

Archivos

Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Boris Julián Pinto Bustamante1_2016.pdf
Tamaño:
163.42 KB
Formato:
Adobe Portable Document Format
Descripción:
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:

Colecciones